Derace L. Schaffer

This profile gathers the share dealings of Derace L. Schaffer across 7 companies, led by Altimmune, Inc., American CareSource Holdings, Inc. and Lantheus Holdings, Inc. We count 104 filings; the first trade dates from 25 January 2006 and the latest from 3 March 2020.

On the open market, the record shows 63 purchases worth €2.7M and 16 sales worth €4.2M. No amount is published for 4 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 10 share grants and 8 option exercises.

A typical purchase (the median) is worth €17k. On 2 out of 25 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 25 purchases show a median change of -18.2%, with the price up in 8% of them. They describe history only and say nothing certain about the share price ahead.

The newest entry dates from 5 March 2020: a share grant, in Lantheus Holdings, Inc. The last purchase on record was published on 2 January 2018, which is 3,217 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.